Lyra Therapeutics (LYRA) Accounts Payables (2019 - 2025)

Quarterly Accounts Payables fell 43.77% to $663000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $663000.0 through Dec 2025, down 43.77% year-over-year, with the annual reading at $663000.0 for FY2025, 43.77% down from the prior year.

Lyra Therapeutics' Accounts Payables history spans 7 years, with the latest figure at $663000.0 for Q4 2025.

  • Accounts Payables came in at $663000.0 for Q4 2025, up from $627000.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $5.1 million in Q3 2023 to a low of $627000.0 in Q3 2025.
  • The 5-year median for Accounts Payables is $2.5 million (2022), against an average of $2.5 million.
  • Year-over-year, Accounts Payables skyrocketed 449.43% in 2021 and then crashed 86.32% in 2025.
  • Lyra Therapeutics' Accounts Payables stood at $3.1 million in 2021, then decreased by 16.29% to $2.6 million in 2022, then grew by 19.69% to $3.1 million in 2023, then tumbled by 62.34% to $1.2 million in 2024, then tumbled by 43.77% to $663000.0 in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Accounts Payables are $663000.0 (Q4 2025), $627000.0 (Q3 2025), and $680000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1.05 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 10.62 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 8.64 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 489.30 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 1.03 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 126.63 Mn
10 Lyra Therapeutics - - - 663,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 663,000.00
Sep 30, 2025 627,000.00
Jun 30, 2025 680,000.00
Mar 31, 2025 725,000.00
Dec 31, 2024 1.18 Mn
Sep 30, 2024 2.29 Mn
Jun 30, 2024 4.97 Mn
Mar 31, 2024 2.84 Mn
Dec 31, 2023 3.13 Mn
Sep 30, 2023 5.05 Mn
Jun 30, 2023 4.19 Mn
Mar 31, 2023 3.95 Mn
Dec 31, 2022 2.62 Mn
Sep 30, 2022 2.90 Mn
Jun 30, 2022 1.67 Mn
Mar 31, 2022 2.41 Mn
Dec 31, 2021 3.13 Mn
Sep 30, 2021 2.91 Mn
Jun 30, 2021 1.90 Mn
Mar 31, 2021 1.17 Mn
Dec 31, 2020 922,000.00
Sep 30, 2020 530,000.00
Jun 30, 2020 1.15 Mn
Mar 31, 2020 1.36 Mn
Dec 31, 2019 1.07 Mn